$CDNA News

CareDx (NASDAQ:CDNA): Strong Growth Meets Technical Setup Quality

CareDx Announces New KOAR Data Linking Elevated AlloSure® Kidney to Nearly 3-Fold Higher Risk of Adverse Graft Outcomes in Patients with Borderline Rejection or TCMR at ASN Kidney Week 2026

Canaccord Genuity Maintains Buy on CareDx, Raises Price Target to $80

CareDx to Report Third Quarter 2026 Financial Results on October 29, 2026

CareDx (NASDAQ:CDNA) Stands Out for High Growth and Improving Fundamentals

CareDx (CDNA) Stock Gets Fair Value Bump After Reimbursement And Analyst Target Changes

CareDx: I Was Wrong, But The Rally Has Outrun The Fundamentals (Rating Upgrade)

CareDx +14% on Fresh $74 Analyst Price Target

BTIG Maintains Buy on CareDx, Raises Price Target to $74

Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently

CAREDX INC (NASDAQ:CDNA): High Growth and Improving Fundamentals Fuel Bullish Case

CareDx (NASDAQ:CDNA) Meets Minervini Trend Template with High-Growth Momentum

Are Medical Stocks Lagging CareDx (CDNA) This Year?

CareDx (NASDAQ:CDNA) Screens Well on High Growth Momentum and Breakout Setup

Canaccord Genuity Initiates Coverage On CareDx with Buy Rating, Announces Price Target of $65

CareDx (NASDAQ:CDNA) Shows Strong Growth Fundamentals by Passing All Eight Rules of Navellier's Screen

CareDx (CDNA) is a Great Momentum Stock: Should You Buy?

CareDx (NASDAQ:CDNA) Combines Strong Growth With a Bullish Technical Setup

CareDx (CDNA) Shares Jumped, So What Is Driving Attention Now?

Is CareDx (CDNA) Fully Priced After Its Strong Three Year Run?